According to research report the cardiac monitoring devices market
is expected to reach $30.56 billion by 2027 from $22.12 billion in
2019, at a CAGR of 4.0%. Factors such as the increasing incidence of
cardiovascular diseases and technological advancements in devices are
expected to propel the growth of the market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=55
Objectives of the Study
• To define, describe, and forecast the cardiac monitoring market by product, end user, and region
•
To provide detailed information regarding the major factors influencing
market growth (drivers, restraints, opportunities, and challenges)
• To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze market opportunities for stakeholders and to provide details of the competitive landscape for market leaders
• To forecast the size of the cardiac monitoring market in North America, Europe, Asia, and the Rest of the World
• To profile key players and comprehensively analyze their core competencies
•
To track and analyze competitive developments such as product launches,
agreements, partnerships, and other developments in the cardiac
monitoring and cardiac rhythm management devices market
Asia is expected to grow at the highest CAGR during the forecast period
On
the basis of region, the CM & CRM devices market is segmented into
North America, Europe, Asia, and RoW. Asia is expected to grow at the
highest CAGR during the forecast period. Factors such as growth in the
geriatric population, growing incidence of chronic diseases, rising
healthcare spending, healthcare reforms for infrastructural development,
growing demand for advanced technologies, and less stringent
regulations are fuelling the demand for CM & CRM devices in this
region.
Based on end user, the cardiac monitoring devices market
is segmented into hospitals, home and ambulatory care settings, and
other end users. In 2017, the hospitals segment accounted for the
largest share of the market. The large share of this segment can
primarily be attributed to the increasing use of these devices in
hospitals, increasing burden of cardiovascular & coronary heart
diseases, increasing number of patient visits to physician offices for
the principal diagnosis of CVD & CHD, and growing number of cardiac
implant procedures.
Based on product, the cardiac rhythm
management devices market is segmented into defibrillators and
pacemakers. The pacemakers segment is projected to grow at the highest
CAGR during the forecast period.
Based on product, the cardiac
monitoring devices market is segmented into ECG devices, ILR, event
monitors, COM monitors, mobile cardiac telemetry, and smart wearable ECG
monitors. The mobile cardiac telemetry segment is projected to grow at
the highest CAGR during the forecast period.
Request Free Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=55
Cardiac Monitoring Devices Market Players
The
cardiac monitoring devices market is dominated by players such as
Medtronic (Ireland), Abbott (US), Boston Scientific (US), BIOTRONIK
(Germany), GE Healthcare (US), and Philips Healthcare (Netherlands)